The global cardiac surgery devices market is expected to enjoy a valuation of US$ 1.7 Billion by the end of 2022 and further expand at a CAGR of 3.6% during the forecast period (2022 to 2032). Sales in the market are expected to reach a valuation of ~US$ 2.4 Billion by 2032 on the back of the rising prevalence of cardiovascular diseases. In terms of product type, the perfusion disposables led the market with a demand share of about 59.1%% in 2021.
Cardiac surgery devices are devices used during an open heart procedure to repair structural defects in the cardiovascular system, such as coronary artery bypass grafting, congenital heart defects, abdominal aortic aneurysm repair, ventricular remodeling, and implantation of cardiac assist devices. Devices such as heart-lung machines are used during cardiothoracic surgery and are most commonly used to perform a cardiopulmonary bypass.
| Attributes | Key Insights |
|---|---|
| Cardiac Surgery Devices Market Value 2021 | US$ 1.6 Billion |
| Estimated Market Size 2022 | US$ 1.7 Billion |
| Projected Market Value 2032 | US$ 2.4 Billion |
| CAGR 2022 to 2032 | 3.6% |
| Market Share of Top 5 Countries | 57.6% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
As per Future Market Insights (FMI), the demand in the global cardiac surgery devices market grew at a CAGR of 3.2% from 2012 to 2021. Sales in the market are poised to expand owing to the rising demand for coronary artery treatment and rising technological advancements in the healthcare industry.
The cardiac surgery devices market was approximately 1% of the global medical device market valued at US$ 457 Billion in 2021. Devices for cardiac surgery are being developed as per patients' needs and on the back of technological advancements in the industry. Hence, key players in the cardiac surgery devices market are launching cutting-edge technologies and designs to strengthen their position in the industry.
Furthermore, there is an increased demand for cardiac surgical equipment due to the rising incidence of cardiovascular diseases, especially among the older population. For instance, it is anticipated that by 2060, 98 million Americans aged 65 and older will be more than a fourfold increase from the current 46 million. The World Health Organization (WHO) report states that cardiovascular disease is the top cause of death worldwide. About 17.9 million deaths globally in 2019 were attributed to cardiovascular illnesses, i.e., 32% of all fatalities.
Further, demand for effective cardiac surgery devices, accessories, and surgical procedures will be fuelled as leading healthcare companies are expanding their cardiovascular devices product portfolio. These companies are also likely to form alliances and acquire companies to generate efficient product advancements that are safe and effective. On the back of these aforementioned factors, the global cardiac surgery devices market is expected to grow at a CAGR of 3.6% during the forecast period from 2022 to 2032.
Favorable Government Investments and Product Launches to be the Key Strategy for Growth
Government authorities in developing countries have been promoting start-up businesses and MNCs to help the healthcare and medical device industries grow commercially. To strengthen their position, leading firms in the medical device industry are collaborating with the government. Hence, with increasing government funding and initiatives in countries such as India, China, and Japan, the cardiac surgery devices market is expected to flourish over the upcoming decade.
Furthermore, the increasing prevalence of chronic diseases and rising traumatic injuries in developing economies is expected to propel growth over the forecast period. Moreover, manufacturers are consistently improving their product portfolio by developing novel and efficient products. Hence, the advent of technologically advanced devices and increased product launches will drive the cardiac surgery devices market.
Principal Consultant
Stringent Regulations and High Cost of Cardiac Surgery Devices to Impede the Growth
The demand for cardiac surgery devices is likely to be restrained due to high pricing and cost-cutting for cardiac surgery device manufacturers. The pricing pressure due to government regulations and competitive pricing on healthcare device manufacturers might create challenges for incumbents and start-ups in developing economies.
Moreover, the cardiac surgery devices market can be negatively affected due to strict and extended approval processes by regulatory authorities such as the FDA and others. Cardiac surgery instruments such as heart-lung machines and heat exchangers are known as class II medical equipment in the USA. FDA.
Therefore, these instruments undergo a special test for their compatibility, performance, sterility, and shelf life. Thus, these devices need to obtain regulatory approval, which is an expensive and lengthy process. This is expected to impede the overall growth in the cardiac surgery devices market.
Rising Cases of Obesity and Cardiovascular Diseases to Boost the Sales
The USA dominated the North American cardiac surgery devices market with a total share of about 86.2% in 2021. Demand in the market is predicted to rise on the back of rising cardiovascular diseases in the country. With the growing prevalence of obesity in the USA a significant share of the population suffers from cardiovascular diseases.
Among these, a considerable percentage of the population undergoes cardiac surgery, as per the study. Backed by this, the demand for advanced cardiac surgery devices is expected to increase over the forecast period.
Additionally, another key factor such as rising healthcare costs is contributing to the USA. cardiac surgery devices market. For instance, in the USA heart disease is the leading cause of death for both genders and for individuals of the majority of racial and ethnic groups. The deaths caused by heart disorders were almost 697,000 people in 2020, according to the report by the Centers for Disease Control and Prevention.
Cost-Effective Treatment Rates in India to Propel Cardiac Surgery Devices Sales
India is set to exhibit growth at a CAGR of nearly 2.7% in the South Asia cardiac surgery devices market during the forecast period. An increasing number of patients undergoing cardiac surgeries is expected to positively affect sales in India. Due to the rising incidence of cardiac conditions, treatment rates are also surging. This is expected to improve the growth in the cardiac surgery devices market.
As per the study in BMJ Journals, approximately 60,000 open heart surgeries are performed annually in India. Therefore, the increasing number of heart bypass surgeries, heart valve surgeries, and heart transplant surgeries are propelling the market for cardiac surgery devices in India.
In India, the cost of surgeries and treatments is comparatively less than in other countries like USA and Europe. Thus, the increasing popularity of medical tourism in India is propelling growth in the market.
Growing Medical Tourism in Germany to Aid the Growth in Cardiac Surgery Devices Market
Germany held approximately a 4.1% share in the global cardiac surgery devices market in 2021 and is projected to display a growth rate of 4.9 % during the forecast period.
The developing healthcare infrastructure and increasing medical tourism in Germany are the key factors propelling the demand for cardiac surgery devices. Germany is one of the countries leading the medical tourism field due to the high international standards and technological advancements such as robotic surgery.
Further, hospitals in Germany are adopting high-quality medical equipment to treat different heart surgeries. Therefore, the technological advancements in cardiac surgery devices are driving growth in Germany.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Over 3/5th of Cardiac Surgery Devices, Sales are to be Contributed by Perfusion Disposables
In terms of product type, perfusion disposables held a share of approximately 59.1% in 2021. Growth in the segment is expected to surge as cases of valvular degeneration in the geriatric population rise. Additionally, the extensively developed healthcare industry and advancements in cardiac surgery devices are also accelerating the growth in the segment.
Rising Incidence of Coronary Heart Diseases to Propel the Adoption in the Market
Based on the procedure, the coronary artery bypass grafting segment accounted for 61.6% of the sales in the global cardiac surgery devices market. The frequency of cardiovascular conditions like coronary heart disease (CHD), peripheral vascular disease, etc. is increasing globally. Hence, the use of coronary artery bypass grafting surgical procedures is expected to surge to treat cardiovascular disorders.
In terms of end users, the hospital's segment held the highest market share of around 60.1% in 2021. In hospitals, the adoption of cardiac treatment and surgeries is benefiting the market growth. The hospitals are improving the quality of treatment and customer service with cost reduction. The hospitals are ahead of the curve in identifying favorable avenues to improve healthcare delivery.
In the cardiac surgery devices market, manufacturers are adopting different strategies to raise their sales and gain revenue. Leading firms are implementing activities like advanced product launches and acquisitions to expand their product portfolio. A few of these strategies undertaken by cardiac surgery devices manufacturers are:
| Attribute | Details |
|---|---|
| Estimated Market Size 2022 | US$ 1.7 Billion |
| Projected Market Value 2032 | US$ 2.4 Billion |
| CAGR 2022 to 2032 | 3.6% |
| Forecast Period | 2022 to 2032 |
| Historical Data Available for | 2012 to 2021 |
| Market Analysis | US$ Million for Value |
| Key Regions Covered | North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, United Kingdom, Germany, Italy, Russia, Spain, France, BENELUX, Nordic Countries, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Turkey, GCC Countries, and South Africa |
| Key Market Segments Covered | Product, Procedure, End User, and Region |
| Key Companies Profiled |
|
The global cardiac surgery devices market is worth US$ 1.6 Billion in 2021.
The cardiac surgery devices market is expected to reach US$ 2.Billion Bn by the end of 2032, with sales expected to register a 3.6% CAGR over the forecast period (2022 to 2032).
Rising cases of heart diseases, increasing demand for large coronary artery treatment, and strategic collaborations among key players are the key trends shaping the cardiac surgery devices industry.
The USA., Japan, Canada, China, and Germany are the top five countries driving the demand for cardiac surgery devices.
The North American cardiac surgery devices market registered a market share of around 40.2 % in the year 2021.
The Japan cardiac surgery devices market is expected to register a growth rate of 2.7% CAGR in the forecast period.
The USA, Japan, and China are the key producers in the cardiac surgery devices market.
The India cardiac surgery devices market is worth US$ 56.4 Million in 2021.
The United Kingdom cardiac surgery devices market is to grow with a growth rate of 55 over the forecast period.
1. Executive Summary | Cardiac Surgery Devices Market
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply-Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Development/Innovation Trends
4. Key Success Factors
4.1. Product Features/ USPs Analysis
4.2. Product Adoption / Usage Analysis
4.3. Key Promotional Strategies, By Key Manufacturers
4.4. Disease Epidemiology
4.5. Regulatory Landscape
4.6. PESTLE Analysis
4.7. Porter’s Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Expenditure
5.1.3. Global Medical Device Market Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Key Player’s Historic Growth
5.2.2. Market Consolidation Activities
5.2.3. New Product Launches / Approvals
5.2.4. Increasing Rate of Cardiac Surgery
5.2.5. Availability of Products
5.2.6. Cost of Products
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis - Impact Assessment
6.1. COVID-19 and Impact Analysis
6.1.1. By Product
6.1.2. By Procedure
6.1.3. By End User
6.1.4. By Region
6.2. 2021 Market Scenario
7. Global Market Demand (in Value or Size in US$ Million) Analysis 2012 to 2021 and Forecast, 2022 to 2032
7.1. Historical Market Value (US$ Million) Analysis, 2012 to 2021
7.2. Current and Future Market Value (US$ Million) Projections, 2022 to 2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By Product
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Million) Analysis By Product, 2012 to 2021
8.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Product, 2022 to 2032
8.3.1. Heart Lung Machine
8.3.2. Breathing Heart Surgery Systems
8.3.2.1. Stabilizers
8.3.2.2. Positioners
8.3.3. Catheters
8.3.3.1. Ablation Catheter
8.3.3.2. Drainage Catheter
8.3.4. Perfusion Disposables
8.3.4.1. Oxygenators
8.3.4.2. Centrifugal Pumps
8.3.4.3. Cardioplegia Delivery System
8.4. Market Attractiveness Analysis By Product
9. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By Procedure
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Million) By Procedure, 2012 to 2021
9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Procedure, 2022 to 2032
9.3.1. Coronary Artery Bypass Grafting
9.3.1.1. On Pump CABG
9.3.1.2. Off Pump CABG
9.3.2. Minimally Invasive Surgery
9.4. Market Attractiveness Analysis By Procedure
10. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By End User
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Million) By End User, 2012 to 2021
10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2022 to 2032
10.3.1. Hospitals
10.3.2. Ambulatory Surgical Centers
10.4. Market Attractiveness Analysis By End User
11. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By Region
11.1. Introduction
11.2. Historical Market Size (US$ Million) Analysis By Region, 2012 to 2021
11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Region, 2022 to 2032
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. East Asia
11.3.5. South Asia
11.3.6. Oceania
11.3.7. Middle East and Africa (MEA)
11.4. Market Attractiveness Analysis By Region
12. North America Market Analysis 2012 to 2021 and Forecast 2022 to 2032
12.1. Introduction
12.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2012 to 2021
12.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2022 to 2032
12.3.1. By Country
12.3.1.1. USA
12.3.1.2. Canada
12.3.2. By Product
12.3.3. By Procedure
12.3.4. By End User
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Product
12.4.3. By Procedure
12.4.4. By End User
12.5. Market Trends
12.6. Key Market Participants - Intensity Mapping
12.7. Drivers and Restraints - Impact Analysis
12.8. Country-Level Analysis & Forecast
12.8.1. USA Market Analysis
12.8.1.1. Introduction
12.8.1.2. Market Analysis and Forecast by Market Taxonomy
12.8.1.2.1. By Product
12.8.1.2.2. By Procedure
12.8.1.2.3. By End User
12.8.2. Canada Market Analysis
12.8.2.1. Introduction
12.8.2.2. Market Analysis and Forecast by Market Taxonomy
12.8.2.2.1. By Product
12.8.2.2.2. By Procedure
12.8.2.2.3. By End User
13. Latin America Market Analysis 2012 to 2021 and Forecast 2022 to 2032
13.1. Introduction
13.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2012 to 2021
13.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2022 to 2032
13.3.1. By Country
13.3.1.1. Mexico
13.3.1.2. Brazil
13.3.1.3. Argentina
13.3.1.4. Rest of Latin America
13.3.2. By Product
13.3.3. By Procedure
13.3.4. By End User
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Product
13.4.3. By Procedure
13.4.4. By End User
13.5. Market Trends
13.6. Key Market Participants - Intensity Mapping
13.7. Drivers and Restraints - Impact Analysis
13.8. Country-Level Analysis & Forecast
13.8.1. Mexico Market Analysis
13.8.1.1. Introduction
13.8.1.2. Market Analysis and Forecast by Market Taxonomy
13.8.1.2.1. By Product
13.8.1.2.2. By Procedure
13.8.1.2.3. By End User
13.8.2. Brazil Market Analysis
13.8.2.1. Introduction
13.8.2.2. Market Analysis and Forecast by Market Taxonomy
13.8.2.2.1. By Product
13.8.2.2.2. By Procedure
13.8.2.2.3. By End User
13.8.3. Argentina Market Analysis
13.8.3.1. Introduction
13.8.3.2. Market Analysis and Forecast by Market Taxonomy
13.8.3.2.1. By Product
13.8.3.2.2. By Procedure
13.8.3.2.3. By End User
14. Europe Market Analysis 2012 to 2021 and Forecast 2022 to 2032
14.1. Introduction
14.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2012 to 2021
14.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2022 to 2032
14.3.1. By Country
14.3.1.1. Germany
14.3.1.2. Italy
14.3.1.3. France
14.3.1.4. United Kingdom
14.3.1.5. Spain
14.3.1.6. BENELUX
14.3.1.7. Nordic Countries
14.3.1.8. Russia
14.3.1.9. Rest of Europe
14.3.2. By Product
14.3.3. By Procedure
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product
14.4.3. By Procedure
14.4.4. By End User
14.5. Market Trends
14.6. Key Market Participants - Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis
14.8. Country-Level Analysis & Forecast
14.8.1. Germany Market Analysis
14.8.1.1. Introduction
14.8.1.2. Market Analysis and Forecast by Market Taxonomy
14.8.1.2.1. By Product
14.8.1.2.2. By Procedure
14.8.1.2.3. By End User
14.8.2. Italy Market Analysis
14.8.2.1. Introduction
14.8.2.2. Market Analysis and Forecast by Market Taxonomy
14.8.2.2.1. By Product
14.8.2.2.2. By Procedure
14.8.2.2.3. By End User
14.8.3. France Market Analysis
14.8.3.1. Introduction
14.8.3.2. Market Analysis and Forecast by Market Taxonomy
14.8.3.2.1. By Product
14.8.3.2.2. By Procedure
14.8.3.2.3. By End User
14.8.4. United Kingdom Market Analysis
14.8.4.1. Introduction
14.8.4.2. Market Analysis and Forecast by Market Taxonomy
14.8.4.2.1. By Product
14.8.4.2.2. By Procedure
14.8.4.2.3. By End User
14.8.5. Spain Market Analysis
14.8.5.1. Introduction
14.8.5.2. Market Analysis and Forecast by Market Taxonomy
14.8.5.2.1. By Product
14.8.5.2.2. By Procedure
14.8.5.2.3. By End User
14.8.6. BENELUX Market Analysis
14.8.6.1. Introduction
14.8.6.2. Market Analysis and Forecast by Market Taxonomy
14.8.6.2.1. By Product
14.8.6.2.2. By Procedure
14.8.6.2.3. By End User
14.8.7. Nordic Countries Market Analysis
14.8.7.1. Introduction
14.8.7.2. Market Analysis and Forecast by Market Taxonomy
14.8.7.2.1. By Product
14.8.7.2.2. By Procedure
14.8.7.2.3. By End User
14.8.8. Russia Market Analysis
14.8.8.1. Introduction
14.8.8.2. Market Analysis and Forecast by Market Taxonomy
14.8.8.2.1. By Product
14.8.8.2.2. By Procedure
14.8.8.2.3. By End User
15. East Asia Market Analysis 2012 to 2021 and Forecast 2022 to 2032
15.1. Introduction
15.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2012 to 2021
15.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2022 to 2032
15.3.1. By Country
15.3.1.1. China
15.3.1.2. Japan
15.3.1.3. South Korea
15.3.2. By Product
15.3.3. By Procedure
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product
15.4.3. By Procedure
15.4.4. By End User
15.5. By End User Market Trends
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
15.8. Country-Level Analysis & Forecast
15.8.1. China Market Analysis
15.8.1.1. Introduction
15.8.1.2. Market Analysis and Forecast by Market Taxonomy
15.8.1.2.1. By Product
15.8.1.2.2. By Procedure
15.8.1.2.3. By End User
15.8.2. Japan Market Analysis
15.8.2.1. Introduction
15.8.2.2. Market Analysis and Forecast by Market Taxonomy
15.8.2.2.1. By Product
15.8.2.2.2. By Procedure
15.8.2.2.3. By End User
15.8.3. South Korea Market Analysis
15.8.3.1. Introduction
15.8.3.2. Market Analysis and Forecast by Market Taxonomy
15.8.3.2.1. By Product
15.8.3.2.2. By Procedure
15.8.3.2.3. By End User
16. South Asia Market Analysis 2012 to 2021 and Forecast 2022 to 2032
16.1. Introduction
16.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2012 to 2021
16.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2022 to 2032
16.3.1. By Country
16.3.1.1. India
16.3.1.2. Indonesia
16.3.1.3. Malaysia
16.3.1.4. Thailand
16.3.1.5. Rest of South Asia
16.3.2. By Product
16.3.3. By Procedure
16.3.4. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product
16.4.3. By Procedure
16.4.4. By End User
16.5. Market Trends
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
16.8. Country-Level Analysis & Forecast
16.8.1. India Market Analysis
16.8.1.1. Introduction
16.8.1.2. Market Analysis and Forecast by Market Taxonomy
16.8.1.2.1. By Product
16.8.1.2.2. By Procedure
16.8.1.2.3. By End User
16.8.2. Indonesia Market Analysis
16.8.2.1. Introduction
16.8.2.2. Market Analysis and Forecast by Market Taxonomy
16.8.2.2.1. By Product
16.8.2.2.2. By Procedure
16.8.2.2.3. By End User
16.8.3. Malaysia Market Analysis
16.8.3.1. Introduction
16.8.3.2. Market Analysis and Forecast by Market Taxonomy
16.8.3.2.1. By Product
16.8.3.2.2. By Procedure
16.8.3.2.3. By End User
16.8.4. Thailand Market Analysis
16.8.4.1. Introduction
16.8.4.2. Market Analysis and Forecast by Market Taxonomy
16.8.4.2.1. By Product
16.8.4.2.2. By Procedure
16.8.4.2.3. By End User
17. Oceania Market 2012 to 2021 and Forecast 2022-2032
17.1. Introduction
17.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2012 to 2021
17.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2022 to 2032
17.3.1. By Country
17.3.1.1. Australia
17.3.1.2. New Zealand
17.3.2. By Product
17.3.3. By Procedure
17.3.4. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product
17.4.3. By Procedure
17.4.4. By End User
17.5. Market Trends
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
17.8. Country-Level Analysis & Forecast
17.8.1. Australia Market Analysis
17.8.1.1. Introduction
17.8.1.2. Market Analysis and Forecast by Market Taxonomy
17.8.1.2.1. By Product
17.8.1.2.2. By Procedure
17.8.1.2.3. By End User
17.8.2. New Zealand Market Analysis
17.8.2.1. Introduction
17.8.2.2. Market Analysis and Forecast by Market Taxonomy
17.8.2.2.1. By Product
17.8.2.2.2. By Procedure
17.8.2.2.3. By End User
18. Middle East and Africa (MEA) Market Analysis 2012 to 2021 and Forecast 2022 to 2032
18.1. Introduction
18.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2012 to 2021
18.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2022 to 2032
18.3.1. By Country
18.3.1.1. GCC Countries
18.3.1.2. Turkey
18.3.1.3. South Africa
18.3.1.4. Rest of the Middle East and Africa
18.3.2. By Product
18.3.3. By Procedure
18.3.4. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Product
18.4.3. By Procedure
18.4.4. By End User
18.5. Market Trends
18.6. Key Market Participants - Intensity Mapping
18.7. Drivers and Restraints - Impact Analysis
18.8. Country-Level Analysis & Forecast
18.8.1. GCC Countries Market Analysis
18.8.1.1. Introduction
18.8.1.2. Market Analysis and Forecast by Market Taxonomy
18.8.1.2.1. By Product
18.8.1.2.2. By Procedure
18.8.1.2.3. By End User
18.8.2. Turkey Market Analysis
18.8.2.1. Introduction
18.8.2.2. Market Analysis and Forecast by Market Taxonomy
18.8.2.2.1. By Product
18.8.2.2.2. By Procedure
18.8.2.2.3. By End User
18.8.3. South Africa Market Analysis
18.8.3.1. Introduction
18.8.3.2. Market Analysis and Forecast by Market Taxonomy
18.8.3.2.1. By Product
18.8.3.2.2. By Procedure
18.8.3.2.3. By End User
19. Market Structure Analysis
19.1. Market Analysis by Tier of Companies
19.2. Market Share Analysis of Top Players (%)
19.3. Market Presence Analysis
19.3.1. By Regional Footprint of Players
19.3.2. Product Footprint of Players
19.3.3. Channel Footprint of Players
20. Competition Analysis
20.1. Competition Dashboard
20.2. Competition Benchmarking
20.3. Competition Deep Dive
20.3.1. Abbott Laboratories
20.3.1.1. Overview
20.3.1.2. Product Portfolio
20.3.1.3. Key Financials
20.3.1.4. SWOT Analysis
20.3.1.5. Key Developments
20.3.1.6. Sales Footprint
20.3.1.7. Strategy Overview
20.3.1.7.1. Marketing Strategy
20.3.1.7.2. Product Strategy
20.3.1.7.3. Channel Strategy
20.3.2. Medtronic Plc.
20.3.2.1. Overview
20.3.2.2. Product Portfolio
20.3.2.3. Key Financials
20.3.2.4. SWOT Analysis
20.3.2.5. Key Developments
20.3.2.6. Sales Footprint
20.3.2.7. Strategy Overview
20.3.2.7.1. Marketing Strategy
20.3.2.7.2. Product Strategy
20.3.2.7.3. Channel Strategy
20.3.3. Boston Scientific Corporation
20.3.3.1. Overview
20.3.3.2. Product Portfolio
20.3.3.3. Key Financials
20.3.3.4. SWOT Analysis
20.3.3.5. Key Developments
20.3.3.6. Sales Footprint
20.3.3.7. Strategy Overview
20.3.3.7.1. Marketing Strategy
20.3.3.7.2. Product Strategy
20.3.3.7.3. Channel Strategy
20.3.4. Lepu Medical Technology Co ltd
20.3.4.1. Overview
20.3.4.2. Product Portfolio
20.3.4.3. Key Financials
20.3.4.4. SWOT Analysis
20.3.4.5. Key Developments
20.3.4.6. Sales Footprint
20.3.4.7. Strategy Overview
20.3.4.7.1. Marketing Strategy
20.3.4.7.2. Product Strategy
20.3.4.7.3. Channel Strategy
20.3.5. LivaNova PLC
20.3.5.1. Overview
20.3.5.2. Product Portfolio
20.3.5.3. Key Financials
20.3.5.4. SWOT Analysis
20.3.5.5. Key Developments
20.3.5.6. Sales Footprint
20.3.5.7. Strategy Overview
20.3.5.7.1. Marketing Strategy
20.3.5.7.2. Product Strategy
20.3.5.7.3. Channel Strategy
20.3.6. Terumo Corporation
20.3.6.1. Overview
20.3.6.2. Product Portfolio
20.3.6.3. Key Financials
20.3.6.4. SWOT Analysis
20.3.6.5. Key Developments
20.3.6.6. Sales Footprint
20.3.6.7. Strategy Overview
20.3.6.7.1. Marketing Strategy
20.3.6.7.2. Product Strategy
20.3.6.7.3. Channel Strategy
20.3.7. Getinge-Maquet Germany Holding GmbH
20.3.7.1. Overview
20.3.7.2. Product Portfolio
20.3.7.3. Key Financials
20.3.7.4. SWOT Analysis
20.3.7.5. Key Developments
20.3.7.6. Sales Footprint
20.3.7.7. Strategy Overview
20.3.7.7.1. Marketing Strategy
20.3.7.7.2. Product Strategy
20.3.7.7.3. Channel Strategy
20.3.8. B. Braun Melsungen AG
20.3.8.1. Overview
20.3.8.2. Product Portfolio
20.3.8.3. Key Financials
20.3.8.4. SWOT Analysis
20.3.8.5. Key Developments
20.3.8.6. Sales Footprint
20.3.8.7. Strategy Overview
20.3.8.7.1. Marketing Strategy
20.3.8.7.2. Product Strategy
20.3.8.7.3. Channel Strategy
20.3.9. C. R. Bard, Inc
20.3.9.1. Overview
20.3.9.2. Product Portfolio
20.3.9.3. Key Financials
20.3.9.4. SWOT Analysis
20.3.9.5. Key Developments
20.3.9.6. Sales Footprint
20.3.9.7. Strategy Overview
20.3.9.7.1. Marketing Strategy
20.3.9.7.2. Product Strategy
20.3.9.7.3. Channel Strategy
20.3.10. Teleflex Incorporated
20.3.10.1. Overview
20.3.10.2. Product Portfolio
20.3.10.3. Key Financials
20.3.10.4. SWOT Analysis
20.3.10.5. Key Developments
20.3.10.6. Sales Footprint
20.3.10.7. Strategy Overview
20.3.10.7.1. Marketing Strategy
20.3.10.7.2. Product Strategy
20.3.10.7.3. Channel Strategy
20.3.11. Angiodynamics
20.3.11.1. Overview
20.3.11.2. Product Portfolio
20.3.11.3. Key Financials
20.3.11.4. SWOT Analysis
20.3.11.5. Key Developments
20.3.11.6. Sales Footprint
20.3.11.7. Strategy Overview
20.3.11.7.1. Marketing Strategy
20.3.11.7.2. Product Strategy
20.3.11.7.3. Channel Strategy
20.3.12. Edwards Lifesciences Corporation
20.3.12.1. Overview
20.3.12.2. Product Portfolio
20.3.12.3. Key Financials
20.3.12.4. SWOT Analysis
20.3.12.5. Key Developments
20.3.12.6. Sales Footprint
20.3.12.7. Strategy Overview
20.3.12.7.1. Marketing Strategy
20.3.12.7.2. Product Strategy
20.3.12.7.3. Channel Strategy
20.3.13. MicroPort Scientific Corporation
20.3.13.1. Overview
20.3.13.2. Product Portfolio
20.3.13.3. Key Financials
20.3.13.4. SWOT Analysis
20.3.13.5. Key Developments
20.3.13.6. Sales Footprint
20.3.13.7. Strategy Overview
20.3.13.7.1. Marketing Strategy
20.3.13.7.2. Product Strategy
20.3.13.7.3. Channel Strategy
20.3.14. Smith Medical
20.3.14.1. Overview
20.3.14.2. Product Portfolio
20.3.14.3. Key Financials
20.3.14.4. SWOT Analysis
20.3.14.5. Key Developments
20.3.14.6. Sales Footprint
20.3.14.7. Strategy Overview
20.3.14.7.1. Marketing Strategy
20.3.14.7.2. Product Strategy
20.3.14.7.3. Channel Strategy
20.3.15. Abiomed, Inc
20.3.15.1. Overview
20.3.15.2. Product Portfolio
20.3.15.3. Key Financials
20.3.15.4. SWOT Analysis
20.3.15.5. Key Developments
20.3.15.6. Sales Footprint
20.3.15.7. Strategy Overview
20.3.15.7.1. Marketing Strategy
20.3.15.7.2. Product Strategy
20.3.15.7.3. Channel Strategy
20.3.16. Estech
20.3.16.1. Overview
20.3.16.2. Product Portfolio
20.3.16.3. Key Financials
20.3.16.4. SWOT Analysis
20.3.16.5. Key Developments
20.3.16.6. Sales Footprint
20.3.16.7. Strategy Overview
20.3.16.7.1. Marketing Strategy
20.3.16.7.2. Product Strategy
20.3.16.7.3. Channel Strategy
20.3.17. Cook Medical Inc
20.3.17.1. Overview
20.3.17.2. Product Portfolio
20.3.17.3. Key Financials
20.3.17.4. SWOT Analysis
20.3.17.5. Key Developments
20.3.17.6. Sales Footprint
20.3.17.7. Strategy Overview
20.3.17.7.1. Marketing Strategy
20.3.17.7.2. Product Strategy
20.3.17.7.3. Channel Strategy
20.3.18. Braile Biomedica
20.3.18.1. Overview
20.3.18.2. Product Portfolio
20.3.18.3. Key Financials
20.3.18.4. SWOT Analysis
20.3.18.5. Key Developments
20.3.18.6. Sales Footprint
20.3.18.7. Strategy Overview
20.3.18.7.1. Marketing Strategy
20.3.18.7.2. Product Strategy
20.3.18.7.3. Channel Strategy
20.3.18.8. Biotronik Inc Overview
20.3.18.9. Product Portfolio
20.3.18.10. Key Financials
20.3.18.11. SWOT Analysis
20.3.18.12. Key Developments
20.3.18.13. Sales Footprint
20.3.18.14. Strategy Overview
20.3.18.14.1. Marketing Strategy
20.3.18.14.2. Product Strategy
20.3.18.14.3. Channel Strategy
21. Assumptions and Acronyms Used
22. Research Methodology
Explore Healthcare Insights
View Reports
Cardiac Surgery Devices Market
